Published Jan 12, 2016

“BUDGET IMPACT ANALYSIS: NEW NORMS”

 Princeton, NJ—January 12, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that its Latin America Consortium Publications Committee has published its first Science Policy Brief—Budget Impact Analysis: New Norms (El Análisis del Impacto Presupuestario: Nuevas Normas). This Science Policy Brief is based on the guidance recommendations from the ISPOR Task Force Report, “Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force,” published in Value in Health [2014 Jan-Feb;17(1):5-14]. The Latin America Consortium Science Policy Brief—Budget Impact Analysis: New Norms—is published in Spanish, Portuguese, and English. This new Science Policy Brief explores the issue of budget impact analyses (BIAs), which are an essential part of assessing affordability of health care interventions and are increasingly required by reimbursement authorities. This Brief, and the original Task Force Report, present updated guidance on methods for undertaking BIAs. For example, recommendations on new intervention BIA design should take into account: (1) relevant features of the health care system, (2) possible access restrictions, (3) the anticipated update of the new intervention, and (4) the use and effects of the current and new interventions. ISPOR Science Policy Briefs are designed to communicate consensus guidance recommendations of ISPOR Good Practices for Outcomes Research Reports in a format that is easily accessible and especially relevant for public and private stakeholders who have non-technical backgrounds. All of the Good Practices for Outcomes Research Reports may be found here. Additional information on the Latin America Consortium may be found here.

###